AI-moderated HCP intelligence for pharma
Know what prescribers think before your next decision.
Continuous conversations with verified HCPs, turned into a decision-ready read in 48-72 hours - alongside the research you already run.
- 48-72h
- to a decision-ready read
- ~¼
- of agency IDI cost
- 60K+
- verified HCPs
- >90%
- interview completion
Panel scale (60,000+ HCPs, 30+ specialties, 19 of the top 20 global pharma) - from ZoomRx public disclosures.
The AE listener (EphMRA 4-criteria detection) runs live in the moderator. Its 24h PV routing is simulated.
Turnaround, cost and completion figures are portfolio targets; the HIPAA / GDPR / 21 CFR chips describe target posture, not audited outcomes.
Trackers tell you what happened last quarter. Sagan tells you what's happening now.
It works alongside your IDIs and trackers - covering the continuous read between waves that they can't.
How it works
Set the question
Pick the decision. We build the guide on a therapeutic-area template.
Sagan interviews
Verified HCPs, async, ~20 min each. The AI probes and adapts.
Get the read
Live dashboard, cited verbatims - in 48-72 hours.
Built for your role
One platform. Every seat at the table.
Insights Director
Answers with cited verbatims the same week - not a six-week deck.
Brand Manager
Why prescribers pick the competitor, this week - not next quarter.
Medical Affairs
A continuous, PV-compliant KOL pulse between congresses.
The difference
Same decision. A fraction of the wait.
Why now
Quarterly isn't fast enough anymore.
Prescriber sentiment now shifts in weeks, not quarters - between every wave.
The brands that see the shift first shape the conversation; the rest react to it.
Build continuous insight into next year's plan before budgets lock.
Pricing
Start with a pilot. Scale when it proves out.
Pilot
from $50K
90 days · one brand
- 50-100 HCP conversations
- Weekly digest + dashboard
- No new procurement
Always-On
Popular$100-140K / yr
Annual · committed capacity
- Continuous listening, all year
- Sagan Agents included
- Quarterly business review
Enterprise
Custom
Franchise-wide
- Unlimited across your brands
- Integrates with your stack
- Dedicated insights partner
Questions
Does this replace our IDIs?
No - it complements them. Sagan covers the continuous, between-wave read that in-depth interviews can't.
Does it need a new procurement cycle?
No - it works within your existing research contract, so there's no new vendor onboarding or security review.
Is the panel pharma-grade?
Yes - 60,000+ verified HCPs, ISO 20252 recruitment, and an in-session AE listener that flags adverse-event mentions against the EphMRA 4-criteria minimum. Try it in the live moderator - describe a patient's side effect and watch it flag.
See Sagan run on your therapeutic area.
Tell us the decision you're chasing. We'll reply within one business day.
An independent PM portfolio artifact by Kaushal Khodifad. The form is live and routes to a real inbox; figures are illustrative.